CONCLUSIONS

Studies attempting to correlate apoptosis with clinical parameters, such as rate of disease progres­sion or response to therapy, have produced a variety of results. In part, differences can be reconciled by the variety of methods by which apoptosis was induced or measured and by the various criteria used to define groups of differing rates of clinical progression or the variety of antiretroviral agents used.

ACKNOWLEDGMENTS

This work was supported by a Wellcome Trust Advanced Clinical Fellowship to DHD (#065054).

REFERENCES

1. Badley, A.D., Pilon, A.A., Landay, A., and Lynch, D.H., Mechanisms of HIV-associated lymphocyte apoptosis, Blood, 96 (9), 2951-2964, 2000.

2. Akbar, A.N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D., Pett, S., Grundy, J.E., and Janossy, G., The significance of low Bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory, J. Exp. Med., 178 (2), 427-438, 1993.

3. Patki, A.H., Georges, D.L., and Lederman, M.M., CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects, Clin. Diagn. Lab. Immunol., 4 (6), 736-741, 1997.

4. Prati, E., Gorla, R., Malacarne, F., Airo, P., Brugnoni, D., Gargiulo, F., Tebaldi, A., Castelli, F., Carosi, G., and Cattaneo, R., Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss, AIDS Res.

5. Meyaard, L., Otto, S.A., Keet, I.P., Roos, M.T., and Miedema, F., Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease, J. Clin. Invest., 93 (3), 982-988, 1994.

6. Buchbinder, S.P., Katz, M.H., Hessol, N.A., O'Malley, P.M., and Holmberg, S.D., Long-term HIV-1 infection without immunologic progression, AIDS, 8 (8), 1123-1128, 1994.

7. Easterbrook, P.J. and Schrager, L.K., Long-term nonprogression in HIV infection: methodological issues and scientific priorities. Report of an international European community—National Institutes of Health Workshop, The Royal Society, London, England, November 27-29, 1995. Scientific Coor­dinating Committee, AIDS Res. Hum. Retroviruses, 14 (14), 1211-1228, 1998.

8. Lifson, A.R., Buchbinder, S.P., Sheppard, H.W., Mawle, A.C., Wilber, J.C., Stanley, M., Hart, C.E., Hessol, N.A., and Holmberg, S.D., Long-term human immunodeficiency virus infection in asymp­tomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics, J. Infect. Dis., 163 (5), 959-965, 1991.

9. Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O.J., Demarest, J.F., Montefiori, D., Orenstein, J.M., Fox, C., Schrager, and L.K., Studies in subjects with long-term nonprogressive human immunodeficiency virus infection, N. Engl. J. Med., 332 (4), 209-216, 1995.

10. Cao, Y., Qin, L., Zhang, L., Safrit, J., and Ho, D.D., Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection, N. Engl. J. Med., 332 (4), 201-208, 1995.

11. Rosenberg, E.S., Billingsley, J.M., Caliendo, A.M., Boswell, S.L., Sax, P.E., Kalams, S.A., and Walker,

B. D., Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia, Science, 278 (5342), 1447-1450, 1997.

12. Paroli, M., Propato, A., Accapezzato, D., Francavilla, V., Schiaffella, E., and Barnaba, V., The immu­nology of HIV-infected long-term non-progressors—a current view, Immunol.

13. Feinberg, M.B. and McLean, A.R., AIDS: decline and fall of immune surveillance? Curr. Biol., 7 (3), R136-R140, 1997.

14. Birch, M.R., Learmont, J.C., Dyer, W.B., Deacon, N.J., Zaunders, J.J., Saksena, N., Cunningham, A. L., Mills, J., and Sullivan, J.S., An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC), J. Clin. Virol., 22 (3), 263-270, 2001.

15. Sheppard, H.W., Lang, W., Ascher, M.S., Vittinghoff, E., and Winkelstein, W., The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels, AIDS, 7 (9), 1159-1166,

1993.

16. Keet, I.P., Krijnen, P., Koot, M., Lange, J.M., Miedema, F., Goudsmit, J., and Coutinho, R.A., Predictors of rapid progression to AIDS in HIV-1 seroconverters, AIDS, 7 (1), 51-57, 1993.

17. Klein, M.R., van Baalen, C.A., Holwerda, A.M., Kerkhof Garde, S.R., Bende, R.J., Keet, I. P., Eeftinck- Schattenkerk, J.K., Osterhaus, A.D., Schuitemaker, H., and Miedema, F., Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics, J. Exp. Med., 181 (4), 1365-1372, 1995.

18. Salerno-Goncalves, R., Lu, W., and Andrieu, J.M., Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease, J. Virol., 74 (14), 6648-6651, 2000.

19. Deacon, N.J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., McPhee, D.A., Greenway, A.L., Ellett, A., and Chatfield, C., Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science, 270 (5238), 988-991,

1995.

20. Lum, J.J., Cohen, O.J., Nie, Z., Weaver, J.G., Gomez, T.S., Yao, X.J., Lynch, D., Pilon, A.A., Hawley,

N., Kim, J.E., Chen, Z., Montpetit, M., Sanchez-Dardon, J., Cohen, E.A., and Badley, A.D., Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis, J.

21. Masciotra, S., Owen, S.M., Rudolph, D., Yang, C., Wang, B., Saksena, N., Spira, T., Dhawan, S., and Lal, R.B., Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression, AIDS, 16 (14), 1887-1898, 2002.

22. Yu, X.F., Wang, Z., Vlahov, D., Markham, R.B., Farzadegan, H., and Margolick, J.B., Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users, J. Infect. Dis., 178 (2), 388-396, 1998.

23. Menzo, S., Sampaolesi, R., Vicenzi, E., Santagostino, E., Liuzzi, G., Chirianni, A., Piazza, M., Cohen,

O. J., Bagnarelli, P., and Clementi, M., Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors, AIDS, 12 (9), 985-997, 1998.

24. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo,

C., Detels, R., and O'Brien, S.J., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, Science, 273 (5283), 1856-1862, 1996.

25. Michael, N.L., Chang, G., Louie, L.G., Mascola, J.R., Dondero, D., Birx, D.L., and Sheppard, H.W., The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression, Nat. Med., 3 (3), 338-340, 1997.

26. Clegg, A.O., Ashton, L.J., Biti, R.A., Badhwar, P., Williamson, P., Kaldor, J.M., and Stewart, G.J., CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV- 1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group, AIDS, 14 (2), 103-108, 2000.

27. Easterbrook, PJ., Rostron, T., Ives, N., Troop, M., Gazzard, B.G., and Rowland-Jones, S.L., Chemo- kine receptor polymorphisms and human immunodeficiency virus disease progression, J. Infect. Dis., 180 (4), 1096-1105, 1999.

28. Smith, M.W., Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Lomb, D.A., Goedert, J.J., O'Brien, T.R., Jacobson, L.P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M.W., and O'Brien, S.J., Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Fran­cisco City Cohort (SFCC), ALIVE Study, Science, 277 (5328), 959-965, 1997.

29. Mulherin, S.A., O'Brien, T.R., Ioannidis, J.P., Goedert, J.J., Buchbinder, S.P., Coutinho, R.A., Jamie­son, B.D., Meyer, L., Michael, N.L., Pantaleo, G., Rizzardi, G.P., Schuitemaker, H., Sheppard, H.W., Theodorou, I.D., Vlahov, D., and Rosenberg, P.S., Effects of CCR5-32 and CCR2-64I alleles on HIV- 1 disease progression: the protection varies with duration of infection, AIDS, 17 (3), 377-387, 2003.

30. Michael, N.L., Louie, L.G., Rohrbaugh, A.L., Schultz, K.A., Dayhoff, D.E., Wang, C.E., and Sheppard, H.W., The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression, Nat. Med., 3 (10), 1160-1162, 1997.

31. Winkler, C., Modi, W., Smith, M.W., Nelson, G.W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., Buchbinder, S., Vittinghoff, E., Goedert, J.J., O'Brien, T.R., Jacobson, L.P., Detels, R., Donfield, S., Willoughby, A., Gomperts, E., Vlahov, D., Phair, J., and O'Brien, S.J., Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), Science, 279 (5349), 389-393, 1998.

32. An, P., Vlahov, D., Margolick, J.B., Phair, J., O'Brien, T.R., Lautenberger, J., O'Brien, S.J., and Winkler, C.A., A tumor necrosis factor-inducible promoter variant of interferon- accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals, J. Infect. Dis., 188 (2), 228-231, 2003.

33. Kaslow, R.A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A.J., Goedert, J.J., Winkler, C., O'Brien, S.J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H., and Mann, D.L., Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection, Nat. Med., 2 (4), 405-411, 1996.

34. Carrington, M., Nelson, G.W., Martin, M.P., Kissner, T., Vlahov, D., Goedert, J.J., Kaslow, R., Buchbinder, S., Hoots, K., and O'Brien, S.J., HLA and HIV-1: heterozygote advantage and B*35- Cw*04 disadvantage, Science, 283 (5408), 1748-1752, 1999.

35. Dubey, D.P., Alper, C.A., Mirza, N.M., Awdeh, Z., and Yunis, E.J., Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity, J. Exp. Med., 179 (4), 1193-1203,

1994.

36. Flores-Villanueva, P.O., Yunis, E.J., Delgado, J.C., Vittinghoff, E., Buchbinder, S., Leung, J.Y., Uglia- loro, A.M., Clavijo, O.P., Rosenberg, E.S., Kalams, S.A., Braun, J.D., Boswell, S.L., Walker, B.D., and Goldfeld, A.E., Control of HIV-1 viremia and protection from AIDS are associated with HLA- Bw4 homozygosity, Proc. Natl. Acad. Sci. U.S.A., 98 (9), 5140-5145, 2001.

37. Martin, M.P., Gao, X., Lee, J.H., Nelson, G.W., Detels, R., Goedert, J.J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., Wilson, M., O'Brien, S.J., and Carrington, M., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS, Nat. Genet., 31 (4), 429-434, 2002.

38. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., and Heard, J.M., Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein, Nat. Med., 2 (3), 338-342, 1996.

39. Ogg, G.S., Jin, X., Bonhoeffer, S., Dunbar, P.R., Nowak, M.A., Monard, S., Segal, J.P., Cao, Y., Rowland-Jones, S.L., Cerundolo, V., Hurley, A., Markowitz, M., Ho, D.D., Nixon, D.F., and McMichael, A.J., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA, Science, 279 (5359), 2103-2106, 1998.

40. Cohen, O.J., Vaccarezza, M., Lam, G.K., Baird, B.F., Wildt, K., Murphy, P.M., Zimmerman, P.A., Nutman, T.B., Fox, C.H., Hoover, S., Adelsberger, J., Baseler, M., Arthos, J., Davey, R.T., Jr., Dewar, R.L., Metcalf, J., Schwartzentruber, D.J., Orenstein, J.M., Buchbinder, S., Saah, A.J., Detels, R., Phair, J., Rinaldo, C., Margolick, J.B., and Fauci, A.S., Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors, J. Clin. Invest., 100 (6), 1581-1589, 1997.

41. Watanabe, M., Ringler, D.J., Fultz, P.N., MacKey, J.J., Boyson, J.E., Levine, C.G., and Letvin, N.L, A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease, J. Virol., 65 (6), 3344-3348, 1991.

42. Johnson, B.K., Stone, G.A., Godec, M.S., Asher, D.M., Gajdusek, D.C., and Gibbs, C.J., Jr., Long­term observations of human immunodeficiency virus-infected chimpanzees, AIDS Res. Hum. Retro­viruses, 9 (4), 375-378, 1993.

43. Gougeon, M.L., Lecoeur, H., Boudet, F., Ledru, E., Marzabal, S., Boullier, S., Roue, R., Nagata, S., and Heeney, J., Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype, J. Immunol., 158 (6), 2964-2976, 1997.

44. Novembre, F.J., de Rosayro, J., Nidtha, S., O'Neil, S.P., Gibson, T.R., Evans-Strickfaden, T., Hart,

C. E., and McClure, H.M., Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees, J. Vιrol., 75 (3), 1533-1539, 2001.

45. O'Neil, S.P., Novembre, F.J., Hill, A.B., Suwyn, C., Hart, C.E., Evans-Strickfaden, T., Anderson, D.C., deRosayro, J., Herndon, J.G., Saucier, M., and McClure, H.M., Progressive infection in a subset of HIV-1-positive chimpanzees, J. Infect. Dis., 182 (4), 1051-1062, 2000.

46. Desrosiers, R.C., Hansen-Moosa, A., Mori, K., Bouvier, D.P., King, N.W., Daniel, M.D., and Ringler,

D. J., Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS, Am. J. Pathol., 139 (1), 29-35, 1991.

47. Schuitemaker, H., Meyaard, L., Kootstra, N.A., Dubbes, R., Otto, S.A., Tersmette, M., Heeney, J.L., and Miedema, F., Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants, J. Infect. Dis., 168 (5), 1140-1147, 1993.

48. Veazey, R.S., DeMaria, M., Chalifoux, L.V., Shvetz, D.E., Pauley, D.R., Knight, H.L., Rosenzweig, M., Johnson, R.P., Desrosiers, R.C., and Lackner, A.A., Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection, Science, 280 (5362), 427-431, 1998.

49. Whetter, L.E., Ojukwu, I.C., Novembre, F.J., and Dewhurst, S., Pathogenesis of simian immunodefi­ciency virus infection, J. Gen. Virol., 80 (Pt. 7), 1557-1568, 1999.

50. Heeney, J., Jonker, R., Koornstra, W., Dubbes, R., Niphuis, H., Di Rienzo, A.M., Gougeon, M.L., and Montagnier, L., The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction, J. Med. Primatol., 22 (2-3), 194-200, 1993.

51. Estaquier, J., Idziorek, T., de Bels, F., Barre-Sinoussi, F., Hurtrel, B., Aubertin, A.M., Venet, A., Mehtali, M., Muchmore, E., and Michel, P., Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections, Proc. Natl. Acad. Sci. U.S.A., 91 (20), 9431-9435, 1994.

52. Finkel, T.H., Tudor-Williams, G., Banda, N.K., Cotton, M.F., Curiel, T., Monks, C., Baba, T.W., Ruprecht, R.M., and Kupfer, A., Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes, Nat. Med., 1 (2), 129-134, 1995.

53. Monceaux, V., Estaquier, J., Fevrier, M., Cumont, M.C., Riviere, Y., Aubertin, A.M., Ameisen, J.C., and Hurtrel, B., Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS, AIDS, 17 (11), 1585-1596, 2003.

54. Wykrzykowska, J.J., Rosenzweig, M., Veazey, R.S., Simon, M.A., Halvorsen, K., Desrosiers, R.C., Johnson, R.P., and Lackner, A.A., Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus, J. Exp. Med., 187 (11), 1767-1778, 1998.

55. Silvestri, G., Sodora, D.L., Koup, R.A., Paiardini, M., O'Neil, S.P., McClure, H.M., Staprans, S.I., and Feinberg, M.B., Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia, Immunity, 18 (3), 441-452, 2003.

56. Dockrell, D.H., The multiple roles of Fas ligand in the pathogenesis of infectious diseases, Clin. Microbiol. Infect., 9 (8), 766-779, 2003.

57. Sasaki, Y., Ami, Y., Nakasone, T., Shinohara, K., Takahashi, E., Ando, S., Someya, K., Suzaki, Y., and Honda, M., Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus, Clin. Exp. Immunol., 122 (3), 381-389, 2000.

58. Iida, T., Ichimura, H., Ui, M., Shimada, T., Akahata, W., Igarashi, T., Kuwata, T., Ido, E., Yonehara, S., Imanishi, J., and Hayami, M., Sequential analysis of apoptosis induction in peripheral blood mononuclear cells and lymph nodes in the early phase of pathogenic and nonpathogenic SIVmac infection, AIDS Res. Hum. Retroviruses, 15 (8), 721-729, 1999.

59. Gougeon, M.L., Lecoeur, H., Heeney, J., and Boudet, F., Comparative analysis of apoptosis in HIV- infected humans and chimpanzees: relation with lymphocyte activation, Immunol. Lett., 51 (1-2), 75-81, 1996.

60. Xu, X.N., Laffert, B., Screaton, G.R., Kraft, M., Wolf, D., Kolanus, W., Mongkolsapay, J., McMichael,

A. J., and Baur, A.S., Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor chain, J. Exp. Med., 189 (9), 1489-1496, 1999.

61. Xu, X.N., Screaton, G.R., Gotch, F.M., Dong, T., Tan, R., Almond, N., Walker, B., Stebbings, R., Kent, K., Nagata, S., Stott, J.E., and McMichael, A.J., Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells, J. Exp. Med., 186 (1), 7-16, 1997.

62. Hodge, S., Novembre, F.J., Whetter, L., Gelbard, H.A., and Dewhurst, S., Induction of Fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14, Virology, 252 (2), 354-363, 1998.

63. Ehret, A., Westendorp, M.O., Herr, I., Debatin, K.M., Heeney, J.L., Frank, R., and Krammer, P.H., Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis, J. Virol., 70 (9), 6502-6507, 1996.

64. Ayyavoo, V., Mahboubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W.V., Green, D.R., and Weiner, D.B., HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor B, Nat. Med., 3 (10), 1117-1123, 1997.

65. Jacotot, E., Ferri, K.F., El Hamel, C., Brenner, C., Druillennec, S., Hoebeke, J., Rustin, P., Metivier,

D., Lenoir, C., Geuskens, M., Vieira, H.L., Loeffler, M., Belzacq, A.S., Briand, J.P., Zamzami, N., Edelman, L., Xie, Z.H., Reed, J.C., Roques, B.P., and Kroemer, G., Control of mitochondrial mem­brane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2, J. Exp. Med., 193 (4), 509-519, 2001.

66. Chang, L.J., Chen, C.H., Urlacher, V., and Lee, T.Z., Differential apoptosis effects of primate lentiviral Vpr and Vpx in mammalian cells, J. Biomed. Sci., 7 (4), 322-333, 2000.

67. Mellors, J.W., Rinaldo, C.R., Jr., Gupta, P., White, R.M., Todd, J.A., and Kingsley, L.A., Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science, 272 (5265), 1167-1170,

1996.

68. Karmochkine, M., Parizot, C., Calvez, V., Coutellier, A., Herson, S., Debre, P., and Gorochov, G., Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 17 (5), 419-423, 1998.

69. Dockrell, D.H., Badley, A.D., Algeciras-Schimnich, A., Simpson, M., Schut, R., Lynch, D.H., and Paya, C.V., Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number, AIDS Res. Hum. Retroviruses, 15 (17), 1509-1518, 1999.

70. Muro-Cacho, C.A., Pantaleo, G., and Fauci, A.S., Analysis of apoptosis in lymph nodes of HIV- infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden, J. Immunol., 154 (10), 5555-5566, 1995.

71. Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I., Hsieh, C.C., Dia, M.C., Gueye,

E. H., and et al., Reduced rate of disease development after HIV-2 infection as compared to HIV-1, Science, 265 (5178), 1587-1590, 1994.

72. Michel, P., Balde, A.T., Roussilhon, C., Aribot, G., Sarthou, J.L., and Gougeon, M.L., Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with 2 microglobulin concentration and disease evolution, J. Infect. Dis., 181 (1), 64-75, 2000.

73. Westendorp, M.O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K.M., and Krammer, P.H., Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature, 375 (6531), 497-500, 1995.

74. Cohen, I., Boya, P., Zhao, L., Metivier, D., Andreau, K., Perfettini, J.L., Weaver, J.G., Badley, A., Taylor, E.W., and Kroemer, G., Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1, Apoptosis, 9 (2), 181-192, 2004.

75. Arthos, J., Cicala, C., Selig, S.M., White, A.A., Ravindranath, H.M., Van Ryk, D., Steenbeke, T.D., Machado, E., Khazanie, P., Hanback, M.S., Hanback, D.B., Rabin, R.L., and Fauci, A.S., The role of the CD4 receptor vs. HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells, Virology, 292 (1), 98-106, 2002.

76. Vlahakis, S.R., Algeciras-Schimnich, A., Bou, G., Heppelmann, C.J., Villasis-Keever, A., Collman, R.C., and Paya, C.V., Chemokine-receptor activation by Env determines the mechanism of death in HIV-infected and uninfected T lymphocytes, J. Clin. Invest., 107 (2), 207-215, 2001.

77. Jekle, A., Keppler, O.T., De Clercq, E., Schols, D., Weinstein, M., and Goldsmith, M.A., In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4- mediated killing of uninfected CD4 T cells, J. Virol., 77 (10), 5846-5854, 2003.

78. Chia, W.K., Freedman, J., Li, X., Salit, I., Kardish, M., and Read, S.E., Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection, AIDS Res. Hum. Retroviruses, 11 (2), 249-256, 1995.

79. Mueller, Y.M., De Rosa, S.C., Hutton, J.A., Witek, J., Roederer, M., Altman, J.D., and Katsikis, P.D., Increased CD95∕Fas-induced apoptosis of HIV-specific CD8(+) T cells, Immunity, 15 (6), 871-882,

2001.

80. Franceschi, C., Franceschini, M.G., Boschini, A., Trenti, T., Nuzzo, C., Castellani, G., C., S., De Rienzo, B., Roncaglia, R., Portolani, M., Pietrosemoli, P., Meacci, M., Pecorari, M., Sabbatini, A., and Malorni, W., Phenotypic characteristics and tendency to apoptosis of peripheral blood mononu­clear cells from HIV+ long term non progressors, Cell Death Differ., 4 (8), 815-823, 1997.

81. Gougeon, M.L., Lecoeur, H., Dulioust, A., Enouf, M.G., Crouvoiser, M., Goujard, C., Debord, T., and Montagnier, L., Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression, J. Immunol., 156 (9), 3509-3520, 1996.

82. Liegler, T.J., Yonemoto, W., Elbeik, T., Vittinghoff, E., Buchbinder, S.P., and Greene, W.C., Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term non- progressors, J. Infect. Dis., 178 (3), 669-679, 1998.

83. Wasmuth, J.C., Klein, K.H., Hackbarth, F., Rockstroh, J.K., Sauerbruch, T., and Spengler, U., Pre­diction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis, J. Acquir. Immune Defic. Syndr., 23 (1), 44-51, 2000.

84. Samuelsson, A., Brostrom, C., van Dijk, N., Sonnerborg, A., and Chiodi, F., Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection — correlation with clinical progression, viral load, and loss of humoral immunity, Virology, 238 (2), 180-188, 1997.

85. Hosaka, N., Oyaizu, N., Than, S., and Pahwa, S., Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants, Clin. Immunol., 95 (1, Pt. 1), 20-25, 2000.

86. Daniel, V., Susal, C., Weimer, R., Zimmermann, R., Huth-Kuhne, A., and Opelz, G., Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases, AIDS Res. Hum. Retroviruses, 17 (4), 329-335, 2001.

87. Krammer, P.H., CD95's deadly mission in the immune system, Nature, 407 (6805), 789-795, 2000.

88. Bottarel, F., Bonissoni, S., Lucia, M.B., Bragardo, M., Bensi, T., Buonfiglio, D., Mezzatesta, C., DiFranco, D., Balotta, C., Capobianchi, M.R., Dianzani, I., Cauda, R., and Dianzani, U., Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency, Hema- tol. J., 2 (4), 220-227, 2001.

89. Cifone, M.G., De Maria, R., Roncaioli, P., Rippo, M.R., Azuma, M., Lanier, L.L., Santoni, A., and Testi, R., Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J. Exp. Med., 180 (4), 1547-1552, 1994.

90. De Simone, C., Cifone, M.G., Alesse, E., Steinberg, S.M., Di Marzio, L., Moretti, S., Famularo, G., Boschini, A., and Testi, R., Cell-associated ceramide in HIV-1-infected subjects, AIDS, 10 (6), 675-676, 1996.

91. Moretti, S., Marcellini, S., Boschini, A., Famularo, G., Santini, G., Alesse, E., Steinberg, S.M., Cifone, M.G., Kroemer, G., and De Simone, C., Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long­term non-progressors, Clin. Exp. Immunol., 122 (3), 364-373, 2000.

92. Giovannetti, A., Pierdominici, M., Mazzetta, F., Mazzone, A.M., Ricci, G., Prozzo, A., Pandolfi, F., Paganelli, R., and Aiuti, F., HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation, AIDS Res. Hum. Retroviruses, 16 (3), 211-219, 2000.

93. Cayota, A., Vuillier, F., Gonzalez, G., and Dighiero, G, CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants, Clin. Exp. Immunol., 104 (1), 11-17, 1996.

94. Ledru, E., Lecoeur, H., Garcia, S., Debord, T., and Gougeon, M.L., Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis, J. Immunol., 160 (7), 3194-3206, 1998.

95. Adams, J.M. and Cory, S., The Bcl-2 protein family: arbiters of cell survival, Science, 281 (5381), 1322-1326, 1998.

96. Miyashita, T. and Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene, Cell, 80 (2), 293-299, 1995.

97. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N., Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis, Science, 288 (5468), 1053-1058, 2000.

98. Cuconati, A., Mukherjee, C., Perez, D., and White, E., DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells, Genes Dev., 17 (23), 2922-2932, 2003.

99. Chipuk, J.E., Kuwana, T., Bouchier-Hayes, L., Droin, N.M., Newmeyer, D.D., Schuler, M., and Green, D.R., Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apo­ptosis, Science, 303 (5660), 1010-1014, 2004.

100. McLinden, R.J., Lewis, B., Michael, N.L., Redfield, R.R., Birx, D.L., and Kim, J.H., Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors, J. Hum. Virol., 1 (1), 30-36, 1997.

101. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J., and Holmberg, S.D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, N. Engl. J. Med., 338 (13), 853-860, 1998.

102. Autran, B., Carcelain, G., Li, T.S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P., and Leibowitch, J., Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease, Science, 277 (5322), 112-116, 1997.

103. Chougnet, C., Fowke, K.R., Mueller, B.U., Smith, S., Zuckerman, J., Jankelevitch, S., Steinberg, S.M., Luban, N., Pizzo, P.A., and Shearer, G.M., Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment, AIDS, 12 (18), 2397-2406, 1998.

104. Badley, A.D., Dockrell, D.H., Algeciras, A., Ziesmer, S., Landay, A., Lederman, M.M., Connick, E., Kessler, H., Kuritzkes, D., Lynch, D.H., Roche, P., Yagita, H., and Paya, C.V., In vivo analysis of Fas/FasL interactions in HIV-infected patients, J. Clin. Invest., 102 (1), 79-87, 1998.

105. Kotler, D.P., Shimada, T., Snow, G., Winson, G., Chen, W., Zhao, M., Inada, Y., and Clayton, F., Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis, AIDS, 12 (6), 597-604, 1998.

106. Dyrhol-Riise, A.M., Stent, G., Rosok, B.I., Voltersvik, P., Olofsson, J., and Asjo, B., The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy, Clin. Immunol., 101 (2), 169-179, 2001.

107. Dyrhol-Riise, A.M., Ohlsson, M., Skarstein, K., Nygaard, S.J., Olofsson, J., Jonsson, R., and Asjo,

B., T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy, Clin. Immunol., 101 (2), 180-191, 2001.

108. Zhang, Z.Q., Notermans, D.W., Sedgewick, G., Cavert, W., Wietgrefe, S., Zupancic, M., Gebhard, K., Henry, K., Boies, L., Chen, Z., Jenkins, M., Mills, R., McDade, H., Goodwin, C., Schuwirth, C.M., Danner, S.A., and Haase, A.T., Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection, Proc. Natl. Acad. Sci. U.S.A., 95 (3), 1154-1159, 1998.

109. Mohri, H., Perelson, A.S., Tung, K., Ribeiro, R.M., Ramratnam, B., Markowitz, M., Kost, R., Hurley, A., Weinberger, L., Cesar, D., Hellerstein, M.K., and Ho, D.D., Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy, J. Exp. Med., 194 (9), 1277-1287, 2001.

110. Nokta, M., Rossero, R., Nichols, J., Rosenbaum, M., and Pollard, R.B., Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations, AIDS Res. Hum. Retroviruses, 15 (3), 255-264, 1999.

111. Ensoli, F., Fiorelli, V., Alario, C., De Cristofaro, M., Santini Muratori, D., Novi, A., Cunsolo, M.G., Mazzetta, F., Giovannetti, A., Mollicone, B., Pinter, E., and Aiuti, F., Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART), Clin. Immunol., 97 (1), 9-20,

2000.

112. Ensoli, F., Fiorelli, V., De Cristofaro, M., Collacchi, B., Santini Muratori, D., Alario, C., Sacco, G., Iebba, F., and Aiuti, F., Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapy, HIV Med., 3 (2), 105-117, 2002.

113. Wasmuth, J.C., Hackbarth, F., Rockstroh, J.K., Sauerbruch, T., and Spengler, U., Changes of lympho­cyte apoptosis associated with sequential introduction of highly active antiretroviral therapy, HIV Med., 4 (2), 111-119, 2003.

114. Landay, A.L., Spritzler, J., Kessler, H., Mildvan, D., Pu, M., Fox, L., O'Neil, D., Schock, B., Kuritzkes, D., and Lederman, M.M., Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor­containing antiretroviral regimen, J. Infect. Dis., 188 (10), 1444-1454, 2003.

115. Aries, S.P., Weyrich, K., Schaaf, B., Hansen, F., Dennin, R.H., and Dalhoff, K., Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1, Scand. J. Immunol., 48 (1), 86-91, 1998.

116. Grelli, S., Campagna, S., Lichtner, M., Ricci, G., Vella, S., Vullo, V., Montella, F., Di Fabio, S., Favalli,

C., Mastino, A., and Macchi, B., Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy, AIDS, 14 (8), 939-949, 2000.

117. Gougeon, M.L., Lecoeur, H. and Sasaki, Y., Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART), Immunol. Lett., 66 (1-3), 97-103, 1999.

118. Bohler, T., Walcher, J., Holzl-Wenig, G., Geiss, M., Buchholz, B., Linde, R., and Debatin, K.M., Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents, AIDS, 13 (7), 779-789, 1999.

119. Amendola, A., Poccia, F., Martini, F., Gioia, C., Galati, V., Pierdominici, M., Marziali, M., Pandolfi,

F., Colizzi, V., Piacentini, M., Girardi, E., and D'Offizi, G., Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group, Clin. Exp. Immunol., 120 (2), 324-332, 2000.

120. Caggiari, L., Zanussi, S., Crepaldi, C., Bortolin, M.T., Caffau, C., D'Andrea, M., and De Paoli, P., Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodefi­ciency virus-positive subjects, Cytometry, 46 (4), 233-237, 2001.

121. de Oliveira Pinto, L.M., Lecoeur, H., Ledru, E., Rapp, C., Patey, O., and Gougeon, M.L., Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro, AIDS, 16 (3), 329-339, 2002.

122. Regamey, N., Harr, T., Battegay, M., and Erb, P., Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2, AIDS Res. Hum. Retroviruses, 15 (9), 803-810, 1999.

123. Airo, P., Torti, C., Uccelli, M.C., Malacarne, F., Palvarini, L., Carosi, G., and Castelli, F., Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection, AIDS Res. Hum. Retroviruses, 16 (17), 1805-1807, 2000.

124. Perfettini, J.L., Roumier, T., Castedo, M., Larochette, N., Boya, P., Raynal, B., Lazar, V., Ciccosanti, F., Nardacci, R., Penninger, J., Piacentini, M., and Kroemer, G., NF-κB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope, J. Exp. Med., 199 (5), 629-640, 2004.

125. Aladdin, H., Katzenstein, T., Dreves, A.M., Ryder, L., Gerstoft, J., Skinhoj, P., Pedersen, B.K., and Ullum, H., T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression, Scand. J. Immunol., 57 (5), 485-492, 2003.

126. Lecossier, D., Bouchonnet, F., Schneider, P., Clavel, F., and Hance, A.J., Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death, J. Infect. Dis., 183 (7), 1009-1016, 2001.

127. De Milito, A., Hejdeman, B., Albert, J., Aleman, S., Sonnerborg, A., Zazzi, M., and Chiodi, F., High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy, AIDS Res. Hum. Retroviruses, 16 (14), 1379-1384, 2000.

128. Benveniste, O., Estaquier, J., Lelievre, J.D., Vilde, J.L., Ameisen, J.C., and Leport, C., Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo, Eur. J. Clin. Microbiol. Infect. Dis., 20 (12), 896-897, 2001.

129. Piconi, S., Trabattoni, D., Fusi, M.L., Milazzo, F., Dix, L.P., Rizzardini, G., Colombo, F., Bray, D., and Clerici, M., Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection, Antiviral. Res., 46 (3), 171-179, 2000.

130. Pilon, A.A., Lum, J.J., Sanchez-Dardon, J., Phenix, B.N., Douglas, R., and Badley, A.D., Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor, Antimicrob. Agents Chemother., 46 (8), 2687-2691, 2002.

131. Sloand, E.M., Maciejewski, J., Kumar, P., Kim, S., Chaudhuri, A., and Young, N., Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells, Blood, 96 (8), 2735-2739, 2000.

132. Phenix, B.N., Lum, J.J., Nie, Z., Sanchez-Dardon, J., and Badley, A.D., Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss, Blood, 98 (4), 1078-1085, 2001.

133. Matarrese, P., Gambardella, L., Cassone, A., Vella, S., Cauda, R., and Malorni, W., Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors, J. Immunol., 170 (12), 6006-6015, 2003.

134. Chavan, S., Kodoth, S., Pahwa, R., and Pahwa, S., The HIV protease inhibitor Indinavir inhibits cell­cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals, Blood, 98 (2), 383-389, 2001.

135. Lu, W. and Andrieu, J.M., HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism, Blood, 96 (1), 250-258, 2000.

136. Phenix, B.N., Cooper, C., Owen, C., and Badley, A.D., Modulation of apoptosis by HIV protease inhibitors, Apoptosis, 7 (4), 295-312, 2002.

137. Puro, V. and Ippolito, G., Brief report: effect of antiretroviral agents on T-lymphocyte subset counts in healthy HIV-negative individuals. The Italian Registry on Antiretroviral Postexposure Prophylaxis, J. Acquir Immune Defic. Syndr., 24 (5), 440-443, 2000.

138 Cooper, C.L., Phenix, B., Mbisa, G., Lum, J.J., Parato, K., Hawley, N., Angel, J.B., and Badley, A.

D., Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo, Front Biosci 9, 338-41, 2004.

139. Collier, A.C., Coombs, R.W., Schoenfeld, D.A., Bassett, R.L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V.J., Friedman, H.M., Merigan, T.C., Reichman, R.C., Hooper, C., and Corey, L., Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group, N. Engl. J. Med., 334 (16), 1011-1017, 1996.

140. Albrecht, M.A., Bosch, R.J., Hammer, S.M., Liou, S.H., Kessler, H., Para, M.F., Eron, J., Valdez, H., Dehlinger, M., and Katzenstein, D.A., Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection, N. Engl. J. Med., 345 (6), 398-407, 2001.

141. van Leth, F., Wit, F.W., Reiss, P., Schattenkerk, J.K., van der Ende, M.E., Schneider, M.M., Mulder, J.W., Frissen, P.H., de Wolf, F., and Lange, J.M., Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy, HIV Med., 5 (2), 74-81, 2004.

142. Chapuis, A.G., Paolo Rizzardi, G., D’Agostino, C., Attinger, A., Knabenhans, C., Fleury, S., Acha- Orbea, H., and Pantaleo, G., Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo, Nat. Med., 6 (7), 762-768, 2000.

143. Grabar, S., Le Moing, V., Goujard, C., Leport, C., Kazatchkine, M.D., Costagliola, D., and Weiss, L., Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy, Ann. Intern. Med., 133 (6), 401-410, 2000.

144. Phenix, B.N., Angel, J.B., Mandy, F., Kravcik, S., Parato, K., Chambers, K.A., Gallicano, K., Hawley- Foss, N., Cassol, S., Cameron, D.W., and Badley, A.D., Decreased HIV-associated T cell apoptosis by HIV protease inhibitors, AIDS Res. Hum. Retroviruses, 16 (6), 559-567, 2000.

145. Pitrak, D.L., Bolanos, J., Hershow, R., and Novak, R.M., Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex vivo rates of apoptosis, AIDS, 15 (10), 1317-1319, 2001.

146. David, D., Keller, H., Nait-Ighil, L., Treilhou, M.P., Joussemet, M., Dupont, B., Gachot, B., Maral, J., and Theze, J., Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy, AIDS, 16 (8), 1093-1101, 2002.

147. Andrieu, J.M., Lu, W., and Levy, R., Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year, J. Infect. Dis., 171 (3), 523-530, 1995.

148. Wallis, R.S., Kalayjian, R., Jacobson, J.M., Fox, L., Purdue, L., Shikuma, C.M., Arakaki, R., Snyder, S., Coombs, R.W., Bosch, R.J., Spritzler, J., Chernoff, M., Aga, E., Myers, L., Schock, B., and Lederman, M.M., A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3), J. Acquir. Immune Defic. Syndr., 32 (3), 281-286, 2003.

149. Cotton, M.F., Ikle, D.N., Rapaport, E.L., Marschner, S., Tseng, P.O., Kurrle, R., and Finkel, T.H., Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection, Pediatr. Res., 42 (5), 656-664, 1997.

150. Roger, P.M., Breittmayer, J.P., Arlotto, C., Pugliese, P., Pradier, C., Bernard-Pomier, G., Dellamonica, P., and Bernard, A., Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients, Clin. Exp. Immunol., 118 (3), 412-416, 1999.

151. Chavan, S.J., Tamma, S.L., Kaplan, M., Gersten, M., and Pahwa, S.G., Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy, Clin. Immunol., 93 (1), 24-33, 1999.

152. Dieye, T.N., Van Vooren, J.P., Delforge, M.L., Liesnard, C., Spontaneous apoptosis and highly active antiretroviral therapy (HAART), Biomed. Pharmacother., 54 (1), 16-20, 2000.

153. Nielsen, S.D., Sorensen, T.U., Ersboll, A.K., Ngo, N., Mathiesen, L., Nielsen, J.O., and Hansen, J.E., Decrease in immune activation in HIV-infected patients treated with highly active antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4+ cells, Scand. J. Infect. Dis., 32 (6), 597-603, 2000.

154. Losa, G.A. and Graber, R., Spontaneous apoptosis, oxidative status and immunophenotype markers in blood lymphocytes of AIDS patients, Anal. Cell Pathol., 21 (1), 11-20, 2000.

155. Benito, J.M., Lopez, M., Martin, J.C., Lozano, S., Martinez, P., Gonzalez-Lahoz, J., and Soriano, V., Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors, AIDS Res. Hum. Retroviruses, 18 (18), 1379-1388,

2002.

156. Roger, P.M., Breittmayer, J.P., Cottalorda, J., Ticchioni, M., Mondain, V., Dellamonica, P., and Bernard, A., Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4(+) T cells, J. Antimicrob. Chemother., 47 (1), 109-112, 2001.

157. Johnson, N. and Parkin, J.M., Anti-retroviral therapy reverses HIV-associated abnormalities in lym­phocyte apoptosis, Clin. Exp. Immunol., 113 (2), 229-234, 1998.

158. Ledru, E., Christeff, N., Patey, O., de Truchis, P., Melchior, J.C., and Gougeon, M.L., Alteration of tumor necrosis factor- T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome, Blood, 95 (10), 3191-3198, 2000.

159. Pandolfi, F., Pierdominici, M., Marziali, M., Livia Bernardi, M., Antonelli, G., Galati, V., D'Offizi,

G., and Aiuti, F., Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV- 1 patients treated with HAART, Clin. Immunol., 94 (3), 153-159, 2000.

160. Sereti, I., Herpin, B., Metcalf, J.A., Stevens, R., Baseler, M.W., Hallahan, C.W., Kovacs, J.A., Davey, R.T., and Lane, H.C., CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients, AIDS, 15 (14), 1765-1775, 2001.

161. Hengge, U.R., Borchard, C., Esser, S., Schroder, M., Mirmohammadsadegh, A., and Goos, M., Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy, AIDS, 16 (2), 151-160, 2002.

162. Grelli, S., Di Traglia, L., Matteucci, C., Lichtner, M., Vullo, V., Di Sora, F., Lauria, F., Montella, F., Favalli, C., Vella, S., Macchi, B., and Mastino, A., Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression, AIDS, 15 (9), 1178-1181,

2001.

163. Moretti, S., Alesse, E., Di Marzio, L., Zazzeroni, F., Ruggeri, B., Marcellini, S., Famularo, G., Steinberg, S.M., Boschini, A., Cifone, M.G., and De Simone, C., Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study, Blood, 91 (10), 3817-3824, 1998.